Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yeying Liu"'
Autor:
Fei Luo, Yingjun Zhou, Jiangang Wang, Yuan Huang, Lingling Zhang, Xi Pan, Jingfei Chen, Yeying Liu, Shousong Cao, Juchang Zhong, Yingjie Zhang
Publikováno v:
Cancer Medicine
Purified vitexin compound 1 (VB1, a neolignan isolated and extracted from the seed of Chinese herb Vitex negundo) is an effective antitumor agent and exhibits promising clinical activity against various cancers including colorectal cancer. However, i
Autor:
Lingling Zhang, Yeying Liu, Guang Luo, Shuaiyu Long, Jing Liu, Nannan Liu, Chuchu Zhang, Yuan Huang, Yingjie Zhang
Publikováno v:
Cell Cycle
P53 is a critical tumor suppressor gene, activating p53 and its downstream targets to induce apoptosis is a promising way for cancer therapy. However, more than 50% of cancer patients have p53 mutations, which may cause cancer therapy resistance, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e84579245f05f821e01607b66434c578
https://europepmc.org/articles/PMC6927701/
https://europepmc.org/articles/PMC6927701/
Autor:
Huanan, Wang, Yeying, Liu, Jie, Ding, Yuan, Huang, Jing, Liu, Nannan, Liu, Yue, Ao, Yi, Hong, Lefeng, Wang, Lingling, Zhang, Jiangang, Wang, Yingjie, Zhang
Publikováno v:
Cancer gene therapy. 27(6)
Colorectal cancer is the third most frequently diagnosed malignancies among both men and women, which has an increased mortality but a poor prognosis. Targeting mTOR becomes an effective approach that shows promising antitumor activities in various c
Autor:
Yeying Liu, Yujie Zhao, Lingling Zhang, Feng Wang, Yingjie Zhang, Li Sun, Xiaoxiao He, Yuan Huang
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 9, Iss 9, Pp 1-13 (2018)
Cell Death and Disease, Vol 9, Iss 9, Pp 1-13 (2018)
Colon cancer is one of the three common malignant tumors, with a lower survival rate. Ipatasertib, a novel highly selective ATP-competitive pan-Akt inhibitor, shows a strong antitumor effect in a variety of carcinoma, including colon cancer. However,